絞り込み

16548

広告

Prevalence, initiating factor, and treatment outcome of medication-related osteonecrosis of the jaw-a 4-year prospective study.

著者 Hallmer F , Andersson G , Götrick B , Warfvinge G , Anderud J , Bjørnland T この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (17view , 0users)

Full Text Sources

Medication-related osteonecrosis of the jaw (MRONJ) has a wide range of prevalence, and a standard therapy has not yet been established. The aim of this study was to analyze the prevalence and initiating factors of MRONJ and the outcomes of surgical therapy.
PMID: 30249535 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード